v3.26.1
DISCONTINUED OPERATIONS (Details Narrative)
₪ in Thousands, $ in Thousands
12 Months Ended
Oct. 20, 2025
USD ($)
shares
Apr. 09, 2025
USD ($)
shares
Apr. 09, 2025
ILS (₪)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
DiscontinuedOperationsAndDisposalGroupsLineItem [Line Items]          
Issuance of shares for the consideration of the acquisition of MitoCareX Bio Ltd $ 4,840     $ 4,840  
Gain on disposal       44  
Proceeds from sale of subsidiary (net of cash disposed)       25
Derecognition of cash and cash equivalents       29  
Proceeds from cash partially offset       $ 4  
Common Stock [Member]          
DiscontinuedOperationsAndDisposalGroupsLineItem [Line Items]          
Sale of shares | shares 1,171,942     1,171,942 [1]  
Issuance of shares for the consideration of the acquisition of MitoCareX Bio Ltd [2]        
Common Stock [Member] | Share Purchase Agreement [Member]          
DiscontinuedOperationsAndDisposalGroupsLineItem [Line Items]          
Sale of shares | shares   4,200,000 4,200,000    
Issuance of shares for the consideration of the acquisition of MitoCareX Bio Ltd   $ 4 ₪ 15    
Common Stock [Member] | Share Purchase Agreement [Member] | N2OFF Ltd [Member]          
DiscontinuedOperationsAndDisposalGroupsLineItem [Line Items]          
Ownership percentage   100.00% 100.00%    
[1] Adjusted to reflect one (1) for thirty-five (35) reverse stock split in September 2025 (see note 1B).
[2] Less than $1 thousand.